NCT06780384View on ClinicalTrials.gov

NTRK 1,2,3 Rearrangements in Patients With Solid Tumors

Active, not recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

February 5, 2020

Primary Completion Date

May 31, 2025

Study Completion Date

August 31, 2025

Conditions
NTRK1/2/3 Fusion Gene Detection
Trial Locations (2)

000144

Grisel Maver Militello, Roma

00144

Istituti Fisioterapici Ospitalieri- Ifo - Istituto Regina Elena, Roma

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Federico Cappuzzo

OTHER

NCT06780384 - NTRK 1,2,3 Rearrangements in Patients With Solid Tumors | Biotech Hunter | Biotech Hunter